Melanoma cells could still partially compensate for reduced cellular bioenergetics by glutamine utilization under dual inhibition of OXPHOS and glycolysis, while triple inhibition of PGC-1α, HIF-1α, and glutamine utilization completely blocked cell growth. The gene discussed is HIF1A; the disease is melanoma.